Since April 2012, the European Medicines Agency has opened one of its “treasure chests” to the public: all reports made by patients, consumers, healthcare professionals, and industry are collected and stored in a database called EudraVigilance. This database contains millions of suspected adverse drug reactions and other information, which before April 2012, only pharmacovigilance experts and the pharmaceutical industry could access.
Desde abril 2012, la Agencia Europea del Medicamento ha abierto al público uno de sus “tesoros”: todos los informes hechos por pacientes, consumidores, profesionales sanitarios e industria se recopilan y guardan en una base de datos llamada Eudravigilance. Está envase de datos contiene millones de sospechas de reacciones adversas a medicamentos e información que hasta abril de 2012 sólo accesible a expertos en farmacovigilancia y la industria farmacéutica.